# REMODULIN
> **NDA021272** · New Drug Application · Sponsor: UNITED THERAP · Approved 2002-05-21
## Drug
- **FDA Application Number:** NDA021272
- **Application type:** New Drug Application
- **Brand name:** REMODULIN
- **Generic name:** TREPROSTINIL
- **Active ingredients:** TREPROSTINIL
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS, SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** UNITED THERAP
- **Manufacturer:** United Therapeutics Corporation
- **First approval:** 2002-05-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021272)
---
*MORVS · CC0 1.0*